Regulatory T cells engineered with a novel insulin-specific chimeric antigen receptor as a candidate immunotherapy for type 1 diabetes-Reference-Cited by-同舟云学术

Regulatory T cells engineered with a novel insulin-specific chimeric antigen receptor as a candidate immunotherapy for type 1 diabetes

Published:2019-09 Issue: Volume:103 Page:102289
ISSN:0896-8411
Container-title:Journal of Autoimmunity
language:en
Short-container-title:Journal of Autoimmunity

Author:

Tenspolde Michel,Zimmermann Katharina,Weber Leonie C.,Hapke Martin,Lieber Maren,Dywicki Janine,Frenzel Andre,Hust Michael,Galla Melanie,Buitrago-Molina Laura E.,Manns Michael P.,Jaeckel Elmar,Hardtke-Wolenski Matthias

Funder

Leona M. and Harry B. Helmsley Charitable Trust

German Research Foundation

Publisher

Elsevier BV

Subject

Immunology,Immunology and Allergy

Reference44 articles.

1. Anti-CD3 antibody induces long-term remission of overt autoimmunity in nonobese diabetic mice;Chatenoud;Proc. Natl. Acad. Sci. U. S. A,1994

2. Anti-CD3 clinical trials in type 1 diabetes mellitus;Daifotis;Clin. Immunol.,2013

3. CD3-specific antibodies: a portal to the treatment of autoimmunity;Chatenoud;Nat. Rev. Immunol.,2007

4. Mucosal administration of CD3-specific monoclonal antibody inhibits diabetes in NOD mice and in a preclinical mouse model transgenic for the CD3 epsilon chain;Kuhn;J. Autoimmun.,2017

5. Autologous nonmyeloablative hematopoietic stem cell transplantation in newly diagnosed type 1 diabetes mellitus;Voltarelli;J. Am. Med. Assoc.,2007

Cited by 136 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Regulatory T cell-based therapy in type 1 diabetes: Latest breakthroughs and evidence;International Immunopharmacology;2024-10

2. IL23R-Specific CAR Tregs for the Treatment of Crohn’s Disease;Journal of Crohn's and Colitis;2024-09-10

3. Biological function of type 1 regulatory cells and their role in type 1 diabetes;Heliyon;2024-09

4. Frontiers in CAR-T cell therapy for autoimmune diseases;Trends in Pharmacological Sciences;2024-09

5. Current progress in CAR-based therapy for kidney disease;Frontiers in Immunology;2024-08-20